History, biological mechanisms of action and clinical indications of intravenous immunoglobulin (IVIG) preparations
Teeling, Jessica.L., Bleeker, Wim.K. and Hack, C.Erik (2002) History, biological mechanisms of action and clinical indications of intravenous immunoglobulin (IVIG) preparations. Reviews in Medical Microbiology, 13, (3), 91-100.
Full text not available from this repository.
Intravenous immunoglobulin (IVIG) preparations were initially introduced as replacement therapy in primary antibody deficiency disorders and, as time passed by, have been found beneficial in patients with autoimmune disorders and systemic inflammatory disease as well. In spite of its widespread use, the precise mechanism of action of IVIG is still largely unknown. Different mechanisms have been proposed, such as Fc[gamma] receptor blockade, inhibition of complement deposition, neutralization of superantigens, neutralization of cytokines and manipulation of the idiotypic network. Although well tolerated by most patients, IVIG may induce side effects in some patients. The fact that most of the commercially available IVIG preparation are free of complement-activating activity suggests that other effector mechanisms are involved. In this review, different biological mechanisms of action of IVIG as well as the causes of side effects are discussed.
|Subjects:||R Medicine > R Medicine (General)
Q Science > QH Natural history > QH301 Biology
|Divisions:||University Structure - Pre August 2011 > School of Biological Sciences
|Date Deposited:||06 Aug 2008|
|Last Modified:||01 Jun 2011 09:37|
|Contributors:||Teeling, Jessica.L. (Author)
Bleeker, Wim.K. (Author)
Hack, C.Erik (Author)
|Date:||1 July 2002|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)